Maziasz TJ[au] - Search Results

Year	Number of Results
1987	1
1991	1
1998	2
1999	1
2000	1
2001	3
2002	1
2004	2
2005	1
2023	0

1

Pharmacology of cyclooxygenase-2 inhibition in the kidney.

Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ. Khan KN, et al. Among authors: maziasz tj. Kidney Int. 2002 Apr;61(4):1210-9. doi: 10.1046/j.1523-1755.2002.00263.x. Kidney Int. 2002. PMID: 11918727 Free article. Review.

2

Cox-2-specific inhibitors: definition of a new therapeutic concept.

Verburg KM, Maziasz TJ, Weiner E, Loose L, Geis GS, Isakson PC. Verburg KM, et al. Among authors: maziasz tj. Am J Ther. 2001 Jan-Feb;8(1):49-64. doi: 10.1097/00045391-200101000-00009. Am J Ther. 2001. PMID: 11304658 Review.

3

Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.

Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K. Gierse JK, et al. Among authors: maziasz tj. J Pharmacol Exp Ther. 2005 Mar;312(3):1206-12. doi: 10.1124/jpet.104.076877. Epub 2004 Oct 19. J Pharmacol Exp Ther. 2005. PMID: 15494548

4

The differential effects of hepatotoxicants on the sulfation pathway in rats.

Maziasz TJ, Liu J, Madhu C, Klaassen CD. Maziasz TJ, et al. Toxicol Appl Pharmacol. 1991 Sep 15;110(3):365-73. doi: 10.1016/0041-008x(91)90039-h. Toxicol Appl Pharmacol. 1991. PMID: 1949007

5

Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.

Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM, Cogburn JN, Gresk CJ, Markos CS, Maziasz TJ, Schoenhard GL, Burton EG. Paulson SK, et al. Among authors: maziasz tj. Drug Metab Dispos. 2000 May;28(5):514-21. Drug Metab Dispos. 2000. PMID: 10772629

6

Diphenylthiazole-induced changes in renal ultrastructure and enzymology: toxicologic mechanisms in polycystic kidney disease?

Hjelle JT, Hjelle JJ, Maziasz TJ, Carone FA. Hjelle JT, et al. Among authors: maziasz tj. J Pharmacol Exp Ther. 1987 Nov;243(2):758-66. J Pharmacol Exp Ther. 1987. PMID: 3119818

7

Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib.

Paulson SK, Engel L, Reitz B, Bolten S, Burton EG, Maziasz TJ, Yan B, Schoenhard GL. Paulson SK, et al. Among authors: maziasz tj. Drug Metab Dispos. 1999 Oct;27(10):1133-42. Drug Metab Dispos. 1999. PMID: 10497139

8

Effect of papillotoxic agents on expression of cyclooxygenase isoforms in the rat kidney.

Khan KN, Alden CL, Gleissner SE, Gessford MK, Maziasz TJ. Khan KN, et al. Among authors: maziasz tj. Toxicol Pathol. 1998 Jan-Feb;26(1):137-42. doi: 10.1177/019262339802600116. Toxicol Pathol. 1998. PMID: 9502396

9

Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets.

Heitmeier MR, Kelly CB, Ensor NJ, Gibson KA, Mullis KG, Corbett JA, Maziasz TJ. Heitmeier MR, et al. Among authors: maziasz tj. J Biol Chem. 2004 Dec 17;279(51):53145-51. doi: 10.1074/jbc.M410978200. Epub 2004 Oct 7. J Biol Chem. 2004. PMID: 15471850 Free article.

10

Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.

Khan KN, Venturini CM, Bunch RT, Brassard JA, Koki AT, Morris DL, Trump BF, Maziasz TJ, Alden CL. Khan KN, et al. Among authors: maziasz tj. Toxicol Pathol. 1998 Sep-Oct;26(5):612-20. doi: 10.1177/019262339802600504. Toxicol Pathol. 1998. PMID: 9789947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results